Share Wealth

Market
  • Markets Navigation
    Company Info.

    Glenmark Pharmaceuticals Ltd.

    Products & Raw Material


    Market Cap.(`) 49249.69 Cr. P/BV 5.83 Book Value (`) 299.28
    52 Week High/Low ( ` ) 1831/1232 FV/ML 1/1 P/E(X) 47.03
    Book Closure 27/09/2024 EPS (`) 37.10 Div Yield (%) 0.14

    You can view the entire product & raw materials mix with Product names, Sales quantity & Value along with percentage contribution from each individual product.

    Product Report
    Product NameYearMonthSales QuantityUOMSales Value (` Crs.)Product Mix (%)
    Pharmaceuticals2024120.00-7,627.8196.66
    Other Operating Revenue2024120.00-241.363.05
    Sale of services2024120.00-21.950.27
    Raw Material Report
    Product NameYear/MonthSales QuantityUOMSales Value (` Crs)Product Mix (%)
    Raw Materials24/030.00Not Reported2,929.04100.00

  • Glenmark Pharmaceuticals Ltd.

    Management Team


    Market Cap.(`) 49249.69 Cr. P/BV 5.83 Book Value (`) 299.28
    52 Week High/Low ( ` ) 1831/1232 FV/ML 1/1 P/E(X) 47.03
    Book Closure 27/09/2024 EPS (`) 37.10 Div Yield (%) 0.14
    You can view Board of Directors and Key Executives of the company.

    Board of Directors
    Sr.No.NameDesignation
    1 Mr. Glenn SaldanhaChairman & Managing Director
    2 Mrs. Cherylann PintoExecutive Director - Corporate Affairs
    3 Mr. V S ManiExecutive Director & Global CFO
    4 Mrs. B E SaldanhaNon Executive Director
    5 Ms. Saira RamasastryInd. Non-Executive Director
    6 Mrs. Vijayalakshmi IyerInd. Non-Executive Director
    7 Mr. Rajesh V DesaiInd. Non-Executive Director
    8 Mr. Dipankar BhattacharjeeInd. Non-Executive Director

    Key Executives
    Sr.No.NameDesignation
    1 Mr. Harish KuberCo. Secretary & Compl. Officer
Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |     |  ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.   |  "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors"   |  ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600   |  For any Grievance mail to : grievance@sharewealthindia.com   |  For any DP Grievance mail to : dpgrievance@sharewealthindia.com.   |  Grievance with SEBI : https://scores.gov.in/scores/Welcome.html